ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $3.35bn
- $3.27bn
- $276.98m
Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: Adaptive Biotechnologies Reports Fourth Quarter Results
Brief: Adaptive Biotechnologies Reports Fourth Quarter 2022 Results, Provides 2023 Outlook
Adaptive Biotechnologies Corp expected to post a loss of 35 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Apollo Global Management, Microsoft, ServiceNow
U.S. STOCKS ON THE MOVE-Nike, Venus Concept, Zymeworks
U.S. STOCKS ON THE MOVE-Nike, Venus Concept, Core Scientific, Zymeworks
U.S. STOCKS ON THE MOVE-Tesla, Nike, Zynerba Pharmaceuticals
U.S. STOCKS ON THE MOVE-Tesla, Nike, Starbucks, Core Scientific
Piper Sandler upgrades Adaptive Biotech on diagnostics strength
Brief: Adaptive Biotechnologies Announces Launch Of Clonoseq® To Assess Minimal Residual Disease (Mrd) In Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Using Circulating Tumor Dna (Ctdna)
U.S. RESEARCH ROUNDUP- Avalonbay Communities, Dominion Energy, PayPal Holdings
Adaptive Biotechnologies Corp reports results for the quarter ended in September - Earnings Summary
Adaptive Biotechnologies Corp expected to post a loss of 38 cents a share - Earnings Preview
Brief: Adaptive Biotechnologies Corp - Adaptive's Work With Epic Will Commence Immediately, With Clonoseq Integration Expected To Go Live In 2023
Brief: Adaptive Biotech Announces Non-Dilutive Royalty Financing With Orbimed For Up To $250 Mln
U.S. RESEARCH ROUNDUP- Analog Devices, Bath & Body Works, Synopsys
Brief: Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
Brief: Adaptive Biotechnologies Receives Expanded Medicare Coverage Of Clonoseq